Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOCO GROUP PLC Director's Dealing 2018

Nov 15, 2018

4931_dirs_2018-11-15_1604d4a7-ac58-4ed3-b2a6-74283fa21f94.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4096H

Nanoco Group PLC

15 November 2018

15 November 2018

NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

Director Share Purchase

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, received notification today that Dr Alison Fielding, a Non-Executive Director of the Group, acquired 47,759 Ordinary shares in the Company as set out below.

Following this transaction, Dr Fielding has a beneficial interest in 91,325 Ordinary Shares, all of which are directly held. This interest represents approximately 0.0319 per cent. of the total voting rights in the Company.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

DR ALISON FIELDING

2.

Reason for the notification: PURCHASE OF ORDINARY SHARES

a)

Position /status

NON-EXECUTIVE DIRECTOR

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:

Identification code

ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

PURCHASE OF ORDINARY SHARES

c)

Price(s) and volume(s)

Price(s) Volume(s)
41.88p 47,759

d)

Aggregated information:

- Aggregated volume

- Price

Price(s) Volume(s)
41.88p 47,759

e)

Date of the transaction

14 NOVEMBER 2018

f)

Place of the transaction

LONDON STOCK EXCHANGE

For further information, please contact:

Nanoco Tel: +44 (0) 161 603 7900
Michael Edelman, Chief Executive Officer
Brian Tenner, Chief Operating and Financial Officer
Caroline Watson, Investor Relations Manager Tel: + 44 (0) 7799 897357
[email protected]
Peel Hunt Tel: +44 (0) 20 7418 8900
Adrian Trimmings
George Sellar
Guy Pengelley
MHP Communications Tel: +44 (0) 20 3128 8570
Reg Hoare / Giles Robinson / Pete Lambie
[email protected]

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. .Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHFKQDDBBDBDDD